Skip to main content

Advertisement

SpringerLink
Log in

A Novel CYBB Variant Causing X-Linked Chronic Granulomatous Disease in a Patient with Empyema

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Rider NL, Jameson MB, Creech CB. Chronic granulomatous disease: epidemiology, pathophysiology, and genetic basis of disease. J Pediatric Infect Dis Soc. 2018;7(suppl_1):S2–5. https://doi.org/10.1093/jpids/piy008.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–91. https://doi.org/10.1038/nature19057.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45(3):246–65. https://doi.org/10.1016/j.bcmd.2010.07.012.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Gungor T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet. 2014;383(9915):436–48. https://doi.org/10.1016/S0140-6736(13)62069-3.

    Article  CAS  PubMed  Google Scholar 

  5. Bhatt ST, Schulz G, Hente M, Slater A, Murray L, Shenoy S, et al. A single-center experience using alemtuzumab, fludarabine, melphalan, and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease. Pediatr Blood Cancer. 2020;67(1):e28030. https://doi.org/10.1002/pbc.28030.

    Article  CAS  PubMed  Google Scholar 

  6. Magnani F, Nenci S, Millana Fananas E, Ceccon M, Romero E, Fraaije MW, et al. Crystal structures and atomic model of NADPH oxidase. Proc Natl Acad Sci U S A. 2017;114(26):6764–9. https://doi.org/10.1073/pnas.1702293114.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Thomsen IP, Smith MA, Holland SM, Creech CB. A comprehensive approach to the management of children and adults with chronic granulomatous disease. J Allergy Clin Immunol Pract. 2016;4(6):1082–8. https://doi.org/10.1016/j.jaip.2016.03.021.

    Article  PubMed  Google Scholar 

  8. Gungor T, Chiesa R. Cellular therapies in chronic granulomatous disease. Front Pediatr. 2020;8:327. https://doi.org/10.3389/fped.2020.00327.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Matute JD, Arias AA, Wright NA, Wrobel I, Waterhouse CC, Li XJ, et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood. 2009;114(15):3309–15. https://doi.org/10.1182/blood-2009-07-231498.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was funded by the Children’s Discovery Institute of Washington University and St. Louis Children’s Hospital.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Washington University School of Medicine, Campus box 8116, One Children’s Place, St. Louis, MO, 63110, USA

    Maleewan Kitcharoensakkul, Zhimin Song, Jeffrey J Bednarski & Mary Dinauer

  2. Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, USA

    Mary Dinauer

Authors
  1. Maleewan Kitcharoensakkul
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhimin Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeffrey J Bednarski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mary Dinauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The first draft of the manuscript was written by Maleewan Kitcharoensakkul, Zhimin Song, Jeffrey J Bednarski, and Mary Dinauer. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Maleewan Kitcharoensakkul.

Ethics declarations

Written informed consent was obtained for research and approved by the author’s Institutional Review Board.

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kitcharoensakkul, M., Song, Z., Bednarski, J.J. et al. A Novel CYBB Variant Causing X-Linked Chronic Granulomatous Disease in a Patient with Empyema. J Clin Immunol 41, 266–269 (2021). https://doi.org/10.1007/s10875-020-00897-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-020-00897-1

Search

Navigation